Why I built Scroobious
I built a medical device company that hit every milestone founders are told will unlock capital. We raised $9.6M, earned FDA registration, secured paying pharma and clinical customers, and published peer-reviewed evidence.
And still, I couldn't raise our Series B.
Our board ultimately authorized an asset sale. The acquiring company, run by an all-male management team, went on to raise $55 million after purchasing our technology, IP, and customer relationships.
I researched the root causes and analyzed data on capital allocation and pattern matching in VC. The bias wasn't anecdotal; it was systemic. Talking with hundreds of founders, investors, and program leaders showed me what was missing: the relationships, and the infrastructure to build them.
I'm not here to fix people or fix VC. I'm here to build a new capital system designed to serve The Rest of Us.
